The FDA has approved two biotechnology companies to begin clinical trials of xenotransplantation, a procedure whereby genetically modified pig organs are transplanted into humans. The breakthrough offers new hope for thousands of Americans suffering kidney failure, many of whom are on the transplant waiting list, The Washington Post reported Feb. 4.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
